B. Sim

发表

Optimized clinical performance of growth hormone with an expanded genetic code

B. E. Kimmel, P. Schultz, Y. Buechler, 2011, Proceedings of the National Academy of Sciences.

Polymorphism within a TCRAV family influences the repertoire through class I/II restriction.

N. Gascoigne, B. Sim, J. L. Wung, 1998, Journal of immunology.

V alpha 3.2 selection in MHC class I mutant mice: evidence for an alternate orientation of TCR-MHC class I interaction.

P. Travers, N. Gascoigne, B. Sim, 1997, Journal of immunology.

Promotion of tumor growth by transfecting antisense DNA to suppress endogenous H-2Kk MHC gene expression in AKR mouse thymoma.

K. Hui, A. A. Oei, T. Foo, 1991, Cellular immunology.

Thymic skewing of the CD4/CD8 ratio maps with the T-cell receptor α-chain locus

R. Schwartz, D. Lo, N. Gascoigne, 1998, Current Biology.

RestrictionInfluences the Repertoire Through Class I/II Polymorphism Within a TCRAV Family

B. Sim, J. L. Wung, 1998 .

Multivalent Antiviral XTEN–Peptide Conjugates with Long in Vivo Half-Life and Enhanced Solubility

M. A. Hartman, C. Gu, Michael Song, 2014, Bioconjugate chemistry.

CLONING AND CHARACTERIZATION OF A POLYMORPHIC CLASS I MHC GENE IN THE AKR LYMPHOMA K36.16

K. Hui, B. Sim, K. M. Hui, 1989, Journal of immunogenetics.

Surprisingly minor influence of TRAV11 (Vα14) polymorphism on NK T-receptor mCD1/α-galactosylceramide binding kinetics

Mitchell Kronenberg, Shane D. Marine, Nathalie Niederberger, 2003, Immunogenetics.

The V alpha 14 NKT cell TCR exhibits high-affinity binding to a glycolipid/CD1d complex.

K. Garcia, M. Kronenberg, N. Gascoigne, 2002, Journal of immunology.

Extension of in vivo half-life of biologically active molecules by XTEN protein polymers.

V. Schellenberger, Vladimir N Podust, V. Podust, 2016, Journal of controlled release : official journal of the Controlled Release Society.

Extension of in vivo half-life of biologically active peptides via chemical conjugation to XTEN protein polymer.

C. Gu, V. Schellenberger, Vladimir N Podust, 2013, Protein engineering, design & selection : PEDS.

The Vα14 NKT Cell TCR Exhibits High-Affinity Binding to a Glycolipid/CD1d Complex1

K. Garcia, M. Kronenberg, N. Gascoigne, 2002, The Journal of Immunology.

Thymic skewing of the CD4/CD8 ratio maps with the T-cell receptor alpha-chain locus.

R. Schwartz, D. Lo, N. Gascoigne, 1998, Current biology : CB.

Control of MHC Restriction by TCR Vα CDR1 and CDR2

Mark I. Greene, Loukia Zerva, M. Greene, 1996, Science.

T cell receptor binding kinetics and special role of Vα in T cell development and activation

Shane D. Marine, Nathalie Niederberger, Shane Marine, 2000, Immunologic research.

A HLA class I cis‐regulatory element whose activity can be modulated by hormones

B. Sim, K. M. Hui, 1994, International journal of cancer.

Reciprocal expression in CD4 or CD8 subsets of different members of the V alpha 11 gene family correlates with sequence polymorphism.

N. Gascoigne, B. Sim, N. R. Gascoigne, 1999, Journal of immunology.

Polymorphism Family Correlates with Sequence 11 Gene Α of Different Members of the V Reciprocal Expression in Cd4 or Cd8 Subsets

N. Gascoigne, B. Sim, N. R. Gascoigne, 2013 .

Abstract 3638: AMX-168, a long-acting, tumor protease-sensitive bispecific precursor for the treatment of solid malignancies

B. Sim, 2017 .

Control of MHC restriction by TCR Valpha CDR1 and CDR2.

M. Greene, N. Gascoigne, M I Greene, 1996, Science.

Preferential expression of TCR V alpha regions in CD4/CD8 subsets: class discrimination or co-receptor recognition?

D. Lo, N. Gascoigne, B. Sim, 1998, Immunology today.

Extension of in vivo half-life of biologically active peptides via chemical conjugation to XTEN protein polymer.

C. Gu, V. Schellenberger, V. Podust, 2013, Protein engineering, design & selection : PEDS.

Extension of in vivo half-life of biologically active molecules by XTEN protein polymers.

V. Schellenberger, V. Podust, R. Peters, 2016, Journal of controlled release : official journal of the Controlled Release Society.